Mark J. Espy

6.9k total citations · 1 hit paper
89 papers, 4.9k citations indexed

About

Mark J. Espy is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mark J. Espy has authored 89 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 21 papers in Infectious Diseases and 16 papers in Molecular Biology. Recurrent topics in Mark J. Espy's work include Cytomegalovirus and herpesvirus research (40 papers), Herpesvirus Infections and Treatments (37 papers) and Virus-based gene therapy research (11 papers). Mark J. Espy is often cited by papers focused on Cytomegalovirus and herpesvirus research (40 papers), Herpesvirus Infections and Treatments (37 papers) and Virus-based gene therapy research (11 papers). Mark J. Espy collaborates with scholars based in United States, Czechia and Belarus. Mark J. Espy's co-authors include Thomas F. Smith, Lynne M. Sloan, Carlos V. Payá, Emily A. Vetter, Franklin R. Cockerill, Jennie Wilson, Mary F. Jones, Seanne P. Buckwalter, Jon E. Rosenblatt and J. R. Uhl and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Hepatology.

In The Last Decade

Mark J. Espy

89 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing

2006 928 citations Mark J. Espy, J. R. Uhl et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Espy United States	39	3.0k	1.5k	813	673	373	89	4.9k
David Nadal Switzerland	43	2.1k 0.7×	1.6k 1.1×	1.5k 1.8×	485 0.7×	460 1.2×	220	5.9k
Paul E. Klapper United Kingdom	37	2.3k 0.8×	1.6k 1.0×	631 0.8×	602 0.9×	231 0.6×	123	4.3k
Francisco M. Marty United States	52	4.8k 1.6×	3.5k 2.3×	1.5k 1.8×	582 0.9×	784 2.1×	204	8.2k
Tetsushi Yoshikawa Japan	45	5.0k 1.7×	2.6k 1.7×	2.0k 2.4×	515 0.8×	225 0.6×	326	7.1k
C. J. A. Sol Netherlands	20	1.6k 0.5×	2.2k 1.5×	411 0.5×	1.2k 1.7×	256 0.7×	42	5.7k
Thomas F. Smith United States	57	6.6k 2.2×	2.6k 1.7×	1.5k 1.8×	1.0k 1.6×	751 2.0×	232	10.2k
Marie L. Landry United States	37	3.0k 1.0×	2.4k 1.6×	363 0.4×	395 0.6×	424 1.1×	139	5.4k
René Boom Netherlands	19	1.7k 0.6×	2.1k 1.4×	230 0.3×	1.2k 1.7×	255 0.7×	27	5.6k
Pauline M. Wertheim-van Dillen Netherlands	8	1.4k 0.5×	1.8k 1.2×	201 0.2×	958 1.4×	265 0.7×	8	4.9k
Udo Reischl Germany	45	2.5k 0.8×	2.1k 1.4×	200 0.2×	1.3k 1.9×	681 1.8×	164	5.7k

Countries citing papers authored by Mark J. Espy

Since Specialization

Citations

This map shows the geographic impact of Mark J. Espy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Espy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Espy more than expected).

Fields of papers citing papers by Mark J. Espy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Espy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Espy. The network helps show where Mark J. Espy may publish in the future.

Co-authorship network of co-authors of Mark J. Espy

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Espy. A scholar is included among the top collaborators of Mark J. Espy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Espy. Mark J. Espy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furst, Joseph W., et al.. (2017). An Assessment of the AdenoPlus Point-of-Care Test for Diagnosing Adenoviral Conjunctivitis and Its Effect on Antibiotic Stewardship. SHILAP Revista de lepidopterología. 1(2). 170–175. 12 indexed citations

Binnicker, Matthew J., et al.. (2017). Automated processing, extraction and detection of herpes simplex virus types 1 and 2: A comparative evaluation of three commercial platforms using clinical specimens. Journal of Clinical Virology. 89. 30–33. 14 indexed citations

Orvidas, Laura J., Eric J. Moore, Matthew J. Binnicker, et al.. (2016). Detection of high-risk human papillomavirus infection in tonsillar specimens using 2 commercially available assays. Diagnostic Microbiology and Infectious Disease. 86(4). 365–368. 6 indexed citations

Dhiman, Neelam, et al.. (2011). Concurrent detection of herpes simplex and varicella-zoster viruses by polymerase chain reaction from the same anatomic location. Diagnostic Microbiology and Infectious Disease. 70(4). 538–540. 7 indexed citations

Leekha, Surbhi, et al.. (2007). Duration of Influenza A Virus Shedding in Hospitalized Patients and Implications for Infection Control. Infection Control and Hospital Epidemiology. 28(9). 1071–1076. 114 indexed citations

Smith, Thomas F., Mark J. Espy, Jayawant N. Mandrekar, et al.. (2007). Quantitative Real-Time Polymerase Chain Reaction for Evaluating DNAemia due to Cytomegalovirus, Epstein-Barr Virus, and BK Virus in Solid-Organ Transplant Recipients. Clinical Infectious Diseases. 45(8). 1056–1061. 27 indexed citations

Viscount, Helen B., Albert Eid, Mark J. Espy, et al.. (2007). Polyomavirus Polymerase Chain Reaction as a Surrogate Marker of Polyomavirus-Associated Nephropathy. Transplantation. 84(3). 340–345. 119 indexed citations

Espy, Mark J., J. R. Uhl, Lynne M. Sloan, et al.. (2006). Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing. Clinical Microbiology Reviews. 19(1). 165–256. 928 indexed citations breakdown →

Razonable, Raymund R., Antonio Rivero, Robert A. Brown, et al.. (2003). Detection of simultaneous β‐herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clinical Transplantation. 17(2). 114–120. 60 indexed citations

10.

Razonable, Raymund R., Kelly W. Burak, Hester van Cruijsen, et al.. (2002). The Pathogenesis of Hepatitis C Virus Is Influenced by Cytomegalovirus. Clinical Infectious Diseases. 35(8). 974–981. 68 indexed citations

11.

Uhl, James R., Constance A. Bell, Lynne M. Sloan, et al.. (2002). Application of Rapid-Cycle Real-Time Polymerase Chain Reaction for the Detection of Microbial Pathogens: The Mayo-Roche Rapid Anthrax Test. Mayo Clinic Proceedings. 77(7). 673–680. 34 indexed citations

12.

Razonable, Raymund R., Robert A. Brown, Jennie Wilson, et al.. (2002). The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 73(6). 968–973. 121 indexed citations

13.

Razonable, Raymund R., Robert A. Brown, Mark J. Espy, et al.. (2002). Selective Reactivation of Human Herpesvirus 6 Variant A Occurs in Critically Ill Immunocompetent Hosts. The Journal of Infectious Diseases. 185(1). 110–113. 88 indexed citations

14.

Mendez, Julio, David H. Dockrell, Mark J. Espy, et al.. (2001). Human β‐Herpesvirus Interactions in Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 183(2). 179–184. 132 indexed citations

15.

Sia, Irene G., et al.. (2000). Cytomegalovirus (CMV) DNA Load Predicts Relapsing CMV Infection after Solid Organ Transplantation. The Journal of Infectious Diseases. 181(2). 717–720. 164 indexed citations

16.

Gabriel, Sherine E., Mark J. Espy, Dean D. Erdman, et al.. (1999). The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation. Arthritis & Rheumatism. 42(6). 1255–1258. 114 indexed citations

17.

Snow, John L., et al.. (1997). Granulomatous Vasculitis Associated With Herpes Virus: A Persistent, Painful, Postherpetic Papular Eruption. Mayo Clinic Proceedings. 72(9). 851–853. 17 indexed citations

18.

Cupp, Michael R., Reza S. Malek, John R. Goellner, Mark J. Espy, & Thomas F. Smith. (1996). Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology. 48(4). 551–555. 30 indexed citations

19.

Ratnam, K V, Mark J. Espy, Sigfrid A. Muller, Thomas F. Smith, & W. P. Daniel Su. (1992). Clinicopathologic study of arsenic-induced skin lesions: No definite association with human papillomavirus. Journal of the American Academy of Dermatology. 27(1). 120–122. 6 indexed citations

20.

Payá, Carlos V., Keith E. Holley, Russell H. Wiesner, et al.. (1990). Early Diagnosis of Cytomegalovirus Hepatitis in Liver Transplant Recipients: Role of Immunostaining, Dna Hybridization and Culture of Hepatic Tissue. Hepatology. 12(1). 119–126. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact